Search | IOVS | ARVO Journals

Showing 1 – 20 of 138

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Efficacy and Safety of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy in the Real-Life Setting

Chiara La Morgia; Catherine Vignal; Valerio Carelli; Mark Moster; Robert C Sergott; Sarah Thornton; Sean P. Donahue; Patrick Yu-Wai-Man; Hélène Dollfus; Thomas Klopstock; Claudia Priglinger; Rabih Hage; Vasily Smirnov; Catherine Cochard; Marie-Bénédicte Rougier; Pierre Lebranchu; Caroline Froment; Frédéric Pollet-Villard; Marie-Alice Laville; Claudia Prospero Ponce; Scott Walter; Francis L Munier; Pauline Zoppe; Magali Taiel; Jose Alain Sahel

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3209.

ARVO Annual Meeting Abstract June 2024

Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy in the Real-Life Setting

Jose Alain Sahel; Catherine Vignal-Clermont; Valerio Carelli; Chiara La Morgia; Mark L. Moster; Robert C Sergott; Sean P. Donahue; Helene Dollfus; Thomas Klopstock; Rabih Hage; Vasily Smirnov; Catherine Cochard; Francis Munier; Pauline Zoppe; Magali Taiel; Patrick Yu-Wai-Man

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):419.

ARVO Annual Meeting Abstract June 2023

Use of lenadogene nolparvovec gene therapy for Leber hereditary optic neuropathy in early access programs

Chiara La Morgia; Catherine Vignal-Clermont; Valerio Carelli; Rabih Hage; Mark L. Moster; Robert C Sergott; Sean P Donahue; Patrick Yu-Wai-Man; Hélène Dollfus; Thomas Klopstock; Vasily M. SMIRNOV; Catherine Cochard; Claudia Prospero Ponce; Francis Munier; Magali Taiel; Jose Sahel

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1956.

ARVO Annual Meeting Abstract June 2022

Genetic bases of retinoblastoma from liquid biopsies

Francesca Cancellieri; Virginie G. Peter; Mathieu Quinodoz; Christina Stathopoulos; Francis L. Munier; Carlo Rivolta

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):503 – A0080.

Genetics March 2022

New COL6A6 Variant Causes Autosomal Dominant Retinitis Pigmentosa in a Four-Generation Family

PDF

Veronika Vaclavik; Leila Tiab; Young Joo Sun; Vinit B. Mahajan; Alexandre Moulin; Nathalie Allaman-Pillet; Francis L. Munier; Daniel F. Schorderet
TAGS: family, retinitis pigmentosa, whole exome sequencing, collagen, immunohistochemistry, proteins
Invest. Ophthalmol. Vis. Sci.. 2022; 63(3):23. https://doi.org/10.1167/iovs.63.3.23

Retina December 2021

Comparative Natural History of Visual Function From Patients With Biallelic Variants in BBS1 and BBS10

PDF

Monika K. Grudzinska Pechhacker; Samuel G. Jacobson; Arlene V. Drack; Matteo Di Scipio; Ine Strubbe; Wanda Pfeifer; Jacque L. Duncan; Helene Dollfus; Nathalie Goetz; Jean Muller; Andrea L. Vincent; Tomas S. Aleman; Anupreet Tumber; Caroline Van Cauwenbergh; Elfride De Baere; Emma Bedoukian; Bart P. Leroy; Jason T. Maynes; Francis L. Munier; Erika Tavares; Eman Saleh; Ajoy Vincent; Elise Heon
TAGS: natural history, phenotype, retinal degeneration, vision, cohort studies, visual acuity
Invest. Ophthalmol. Vis. Sci.. 2021; 62(15):26. https://doi.org/10.1167/iovs.62.15.26

ARVO Annual Meeting Abstract June 2021

Natural history study of visual function in patients with BBS1- and BBS10 -related retinal degeneration.

Monika Grudzinska Pechhacker; Samuel G Jacobson; Arlene V Drack; Matteo Di Scipio; Ine Stubbe; Jacque L Duncan; Helene Dollfus; Andrea L Vincent; Tomas S Aleman; Bart Leroy; Jason Maynes; Francis Munier; Erika Tavares; Eman Saleh; Ajoy Vincent; Elise Heon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3284.

Genetics April 2020

Retinal Structure in RPE65 -Associated Retinal Dystrophy

PDF

Neruban Kumaran; Michalis Georgiou; James W. B. Bainbridge; Mette Bertelsen; Michael Larsen; Fiona Blanco-Kelly; Carmen Ayuso; Hoai Viet Tran; Francis L. Munier; Angelos Kalitzeos; Michel Michaelides
TAGS: retina, retinal dystrophies, rpe65 protein, spectral domain-optical coherence tomography, eye, fundus autofluorescence imaging
Invest. Ophthalmol. Vis. Sci.. 2020; 61(4):47. https://doi.org/10.1167/iovs.61.4.47

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Retinal and Choroidal Macular Features in Eyes affected by Vascular Choroidopathy after Intra-Arterial Chemotherapy for Retinoblastoma assessed by Optical Coherence Tomography

Jessica Sergenti; Marie-Claire Gaillard; Christina Stathopoulos; Susan Houghton; Francesco Puccinelli; Maja Beck-Popovic; Francis Munier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2324.

ARVO Annual Meeting Abstract July 2019

Novel compound heterozygote mutations in CYP2U1 can cause maculopathy with or without neurological signs of hereditary spastic paraplegia HSP56

Veronika Vaclavik; Emanuelle Ranza; Francis Munier; Franz-Josef Holzer; Michel Guipponi; Stylianos Antonarakis; Daniel F Schorderet

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2930.

ARVO Annual Meeting Abstract June 2017

Subfoveal nodule in Coats disease: towards an updated classification predicting visual prognosis

Alejandra Daruich; Alexandre Moulin; Hoai Viet Tran; Alexandre Matet; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2423.

ARVO Annual Meeting Abstract June 2017

Automatic Segmentation of Retinoblastoma in Fundus Image Photography using Convolutional Neural Networks

Carlos Ciller; Sandro Ivo S. De Zanet; Stefanos Apostolopoulos; Francis L Munier; Sebastian Wolf; Jean-Philippe Thiran; Meritxell Bach Cuadra; Raphael Sznitman

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3332.

ARVO Annual Meeting Abstract June 2017

Mutations in MFSD8 cause early and late onset Autosomal Recessive Macular Dystrophy in Switzerland

Veronika Vaclavik; Daniel F Schorderet; Francis L Munier; Hoai Viet Tran; Margarita Todorova

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2778.

ARVO Annual Meeting Abstract June 2017

Development of a technique for assessment of retinoblastoma cell dissemination after intravitreal injection of chemotherapy

URSULA ANDREA WINTER; Michael Nicolas; Francis L Munier; Mariana Sgroi; Adriana Fandiño; Guillermo Chantada; Paula Schaiquevich

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3333.

ARVO Annual Meeting Abstract June 2017

Anti-VEGF therapy for secondary neovascularization following intra-arterial chemotherapy for advanced retinoblastoma

Francis L Munier; Marie-Claire Gaillard; Francesco Puccinelli; Ciara Bergin; Susan Houghton; Alexandre Moulin; Maja Beck-Popovic

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3338.

ARVO Annual Meeting Abstract June 2017

Para-arterial preservation of the inner retinal layer in Leber congenital amaurosis: an early and transient sign of retinal degeneration

Ariane de Lassus; Bart Peter Leroy; Veronika Vaclavik; Daniel F Schorderet; Francis L Munier; Hoai Viet Tran

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2762.

ARVO Annual Meeting Abstract September 2016

Extramacular fibrosis in Coats’ disease

Alejandra Daruich; Alexandre Matet; Marie-Claire Gaillard; Hoai Viet Tran; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):160.

ARVO Annual Meeting Abstract September 2016

Concomitant first line intra-arterial (IAC) and intra-vitreal (IVC) chemotherapy with melphalan for unilateral group D retinoblastoma (Rb) with diffuse vitreous seeding at presentation

Francis L Munier; Marie-Claire Gaillard; Christina Stathopoulos; Maja Beck-Popovic; Francesco Puccinelli; Susan L Houghton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3682.

ARVO Annual Meeting Abstract September 2016

Multimodal analysis of macular toxicity following intra-arterial (IAC) and/or intravitreal (IVC) melphalan in retinoblastoma (Rb): evidence for infra-clinical changes by optic coherence tomography (OCT) and adaptive optics (AO)

yousra Falfoul; Ali Dirani; Marie-Claire Gaillard; Francesco Puccinelli; Maja Beck-Popovic; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3683.

ARVO Annual Meeting Abstract September 2016

Combined Melphalan/Topotecan intra-arterial chemotherapy (MT-IAC) for salvage in retinoblastoma relapse following melphalan intra-arterial chemotherapy (M-IAC)

Anthony Manassero; Marie-Claire Gaillard; christina stathopoulos; sue houghton; francesco puccinelli; maja Beck-Popovic; Francis L Munier

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3684.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Efficacy and Safety of Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy in the Real-Life Setting

Lenadogene Nolparvovec Gene Therapy for Leber Hereditary Optic Neuropathy in the Real-Life Setting

Use of lenadogene nolparvovec gene therapy for Leber hereditary optic neuropathy in early access programs

Genetic bases of retinoblastoma from liquid biopsies

New COL6A6 Variant Causes Autosomal Dominant Retinitis Pigmentosa in a Four-Generation Family

Comparative Natural History of Visual Function From Patients With Biallelic Variants in BBS1 and BBS10

Natural history study of visual function in patients with BBS1- and BBS10 -related retinal degeneration.

Retinal Structure in RPE65 -Associated Retinal Dystrophy

Retinal and Choroidal Macular Features in Eyes affected by Vascular Choroidopathy after Intra-Arterial Chemotherapy for Retinoblastoma assessed by Optical Coherence Tomography

Novel compound heterozygote mutations in CYP2U1 can cause maculopathy with or without neurological signs of hereditary spastic paraplegia HSP56

Subfoveal nodule in Coats disease: towards an updated classification predicting visual prognosis

Automatic Segmentation of Retinoblastoma in Fundus Image Photography using Convolutional Neural Networks

Mutations in MFSD8 cause early and late onset Autosomal Recessive Macular Dystrophy in Switzerland

Development of a technique for assessment of retinoblastoma cell dissemination after intravitreal injection of chemotherapy

Anti-VEGF therapy for secondary neovascularization following intra-arterial chemotherapy for advanced retinoblastoma

Para-arterial preservation of the inner retinal layer in Leber congenital amaurosis: an early and transient sign of retinal degeneration

Extramacular fibrosis in Coats’ disease

Concomitant first line intra-arterial (IAC) and intra-vitreal (IVC) chemotherapy with melphalan for unilateral group D retinoblastoma (Rb) with diffuse vitreous seeding at presentation

Multimodal analysis of macular toxicity following intra-arterial (IAC) and/or intravitreal (IVC) melphalan in retinoblastoma (Rb): evidence for infra-clinical changes by optic coherence tomography (OCT) and adaptive optics (AO)

Combined Melphalan/Topotecan intra-arterial chemotherapy (MT-IAC) for salvage in retinoblastoma relapse following melphalan intra-arterial chemotherapy (M-IAC)

To View More...

You must be signed into an individual account to use this feature.